CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist
  • 30.18
  • -0.36-1.18%
Market Closed Jan 3 15:00 CST
23.24BMarket Cap24.92P/E (TTM)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tianjin Pharmaceutical Da Ren Tang Group Corporation Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.65B
--
-3.43%
EPS
--
0.19
--
--
Analyst Rating
Strong Buy

Jan 4, 2025

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 9.544B --
-- 2024/FY -- / 8.725B --
Mar 30, 2024 2023/FY 8.222B / 8.549B --
Mar 31, 2023 2022/FY 8.249B / 7.337B --
Mar 31, 2021 2020/FY 6.604B / 7.727B --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.544B--
--2024/FY-- / 8.725B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--

Unlock Free Earnings Estimates

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Reports

  • Daren Tang: Daren Tang Third Quarter Report 2024

    Oct 31, 2024 00:00

  • Da Ren Tang Third Quarter Report 2024

    Oct 31, 2024 00:00

  • tj darentang Half-Year Report 2024

    Aug 15, 2024 00:00

  • Summary of tj darentang's Half-Year Report for 2024.

    Aug 15, 2024 00:00

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Baotou Tianhe Magnetics Technology
    603072
    48.00 +290.24%
    HuangShan Googe
    301581
    70.01 +154.58%
    Geovis Insighter Technology
    920116
    45.63 +30.00%
    CHICHENG ELECTRIC
    834407
    23.69 +29.95%
    Xdc Industries(Shenzhen)Limited
    300615
    16.55 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 4, 2025

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Traditional Chinese Medicine Concept
    Traditional Chinese Medicine Concept
    Intraday-1.01%
    ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday-1.26%
    State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday-1.37%